Enhancing medical affairs capabilities

A more effective global Medical Affairs capability that consistently delivers highly effective publication strategies


Inconsistent development and delivery of publication strategies across the Medical Affairs’ Scientific Communications Leaders (SCLs) responsible for a Big Pharma’s top therapeutic area

Many SCLs were not viewed as business partners by development and commercial teams, significantly hindering their ability to deliver effective publication strategies for the portfolio


Structured discussions with 16 development, medical and commercial leaders to gain insight into their expectations and experiences of working with SCLs and of publications

Clearly identified gaps in business partnership, strategy development and publication expertise

Worked closely with SCLs to establish an improved way of operating that included sharing best practice examples and establishing a network of business partnering relationships

  • Enhanced capabilities with new forums for sharing outputs, insights and methodologies, and for sharing experiences in successfully building business partnerships
  • Consistent delivery of effective publication strategies through genuine partnerships between medical affairs and other functions